Last Price$64.9(1.2%)
Market Cap$82.3B
LTM Gross margin
13.8%
5Y avg
16.8%
Medical - Healthcare Plans industry
median
34.2%
Stock quality & Intrinsic value
5/10
2.2% undervalued
CVS Health Corporation Gross margin
Annual
Quarterly
LTM
Industry median
Company stand-alone
Crunching data... Almost there!
| Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 26.2% | 26.8% | 21.1% | 20.9% | 20.7% | 21.1% | 19.2% | 18.3% | 18.8% | 18.2% | 17.3% | 16.2% | 15.4% | 16.2% | 17.7% | 18.3% | 17.8% | 16.9% | 15.2% | 13.8% |
Overvalued or undervalued?
Check the intrinsic value for CVS
and see if it's the right time to invest.
CVS Health Corporation (CVS) Gross margin comparison analysis
General
LTM Gross margin
OTHER METRICS
Company name
Revenue growth
EPS growth
Net Income margin
CVS Health CorporationCVS
13.8%
4.2%
(43.6%)
1.2%
Median Peer Set
39.1%
8.7%
(2.4%)
1.5%
Oscar Health, Inc.OSCR
100.0%
56.5%
N/A
0.3%
Humana Inc.HUM
91.9%
10.7%
(50.1%)
1.0%
Clover Health Investments, Corp.CLOV
53.9%
(41.5%)
(31.3%)
(10.5%)
Cigna CorporationCI
48.9%
8.4%
(18.9%)
2.6%
Elevance Health Inc.ELV
43.4%
3.2%
(0.0%)
3.4%
Molina Healthcare, Inc.MOH
34.7%
19.3%
9.2%
2.9%
Alignment Healthcare, Inc.ALHC
33.7%
27.2%
(4.8%)
(8.1%)
UnitedHealth Group IncorporatedUNH
21.9%
8.9%
(35.7%)
3.6%
Centene CorporationCNC
13.1%
5.9%
27.4%
2.0%
Bright Health Group, Inc.BHG
7.8%
(51.9%)
86.2%
(103.4%)
CVS key stats
USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
| Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
% growth | 37,006.7 21.0% | 43,821.4 18.4% | 76,329.5 74.2% | 87,472.0 14.6% | 98,215.0 12.3% | 95,778.0 (2.5%) | 107,080.0 11.8% | 123,120.0 15.0% | 126,761.0 3.0% | 139,367.0 9.9% | 153,290.0 10.0% | 177,546.0 15.8% | 184,786.0 4.1% | 194,579.0 5.3% | 256,776.0 32.0% | 268,706.0 4.6% | 292,111.0 8.7% | 322,467.0 10.4% | 357,776.0 10.9% | 372,809.0 4.2% |
| Cost of Goods Sold (COGS) | 27,312.1 | 32,079.2 | 60,221.8 | 69,182.0 | 77,857.0 | 75,559.0 | 86,518.0 | 100,632.0 | 102,978.0 | 114,000.0 | 126,762.0 | 148,712.0 | 156,258.0 | 163,041.0 | 211,248.0 | 219,660.0 | 239,991.0 | 267,965.0 | 303,345.0 | 321,408.0 |
% margin | 9,694.6 26.2% | 11,742.2 26.8% | 16,107.7 21.1% | 18,290.0 20.9% | 20,358.0 20.7% | 20,219.0 21.1% | 20,562.0 19.2% | 22,488.0 18.3% | 23,783.0 18.8% | 25,367.0 18.2% | 26,528.0 17.3% | 28,834.0 16.2% | 28,528.0 15.4% | 31,538.0 16.2% | 45,528.0 17.7% | 49,046.0 18.3% | 52,120.0 17.8% | 54,502.0 16.9% | 54,431.0 15.2% | 51,401.0 13.8% |
| Operating Expenses | 7,675.1 | 9,300.6 | 11,314.4 | 12,244.0 | 13,933.0 | 14,082.0 | 14,231.0 | 15,278.0 | 15,746.0 | 16,568.0 | 17,053.0 | 18,448.0 | 18,990.0 | 27,517.0 | 33,541.0 | 35,135.0 | 38,810.0 | 46,548.0 | 40,688.0 | 41,606.0 |
| Research & Development Expenses (R&D) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Selling, General & Administrative Expenses (SG&A) | 7,675.1 | 9,300.6 | 11,314.4 | 12,244.2 | 13,933.0 | 14,092.0 | 14,231.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | (1,279.0) |
% margin | 2,019.5 5.5% | 2,441.6 5.6% | 4,793.3 6.3% | 6,046.0 6.9% | 6,425.0 6.5% | 6,137.0 6.4% | 6,331.0 5.9% | 7,210.0 5.9% | 8,037.0 6.3% | 8,799.0 6.3% | 9,475.0 6.2% | 10,386.0 5.8% | 9,538.0 5.2% | 4,021.0 2.1% | 11,987.0 4.7% | 13,911.0 5.2% | 13,310.0 4.6% | 7,954.0 2.5% | 13,743.0 3.8% | 8,516.0 2.3% |
| Interest Income | 0.0 | 0.0 | 0.0 | 21.0 | 5.0 | 3.0 | 4.0 | 4.0 | 8.0 | 15.0 | 21.0 | 20.0 | 21.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Interest Expense | 0.0 | 0.0 | 0.0 | 530.0 | 530.0 | 539.0 | 588.0 | 561.0 | 517.0 | 615.0 | 859.0 | 1,078.0 | 1,062.0 | 2,619.0 | 3,035.0 | 2,907.0 | 2,503.0 | 2,287.0 | 2,658.0 | 2,958.0 |
| Pre-tax Income | 1,909.0 | 2,225.8 | 4,358.7 | 5,537.0 | 5,900.0 | 5,601.0 | 5,747.0 | 6,305.0 | 7,528.0 | 7,678.0 | 8,616.0 | 8,637.0 | 8,268.0 | 1,406.0 | 8,997.0 | 9,770.0 | 10,537.0 | 5,836.0 | 11,173.0 | 6,148.0 |
% effective tax rate | 684.3 35.8% | 856.9 38.5% | 1,721.7 39.5% | 2,193.0 39.6% | 2,200.0 37.3% | 2,179.0 38.9% | 2,258.0 39.3% | 2,436.0 38.6% | 2,928.0 38.9% | 3,033.0 39.5% | 3,386.0 39.3% | 3,317.0 38.4% | 1,637.0 19.8% | 2,002.0 142.4% | 2,366.0 26.3% | 2,569.0 26.3% | 2,548.0 24.2% | 1,509.0 25.9% | 2,805.0 25.1% | 1,562.0 25.4% |
% margin | 1,224.7 3.3% | 1,368.9 3.1% | 2,637.0 3.5% | 3,212.0 3.7% | 3,696.0 3.8% | 3,427.0 3.6% | 3,462.0 3.2% | 3,864.0 3.1% | 4,592.0 3.6% | 4,644.0 3.3% | 5,237.0 3.4% | 5,317.0 3.0% | 6,622.0 3.6% | (594.0) (0.3%) | 6,634.0 2.6% | 7,179.0 2.7% | 8,001.0 2.7% | 4,311.0 1.3% | 8,344.0 2.3% | 4,614.0 1.2% |
| EPS | 1.49 | 1.65 | 1.97 | 2.23 | 2.58 | 2.51 | 2.59 | 3.05 | 3.77 | 3.98 | 4.66 | 4.93 | 6.47 | (0.57) | 5.10 | 5.48 | 6.00 | 3.29 | 6.49 | 3.66 |
| Diluted EPS | 1.45 | 1.60 | 1.92 | 2.18 | 2.55 | 2.49 | 2.57 | 3.03 | 3.74 | 3.96 | 4.63 | 4.90 | 6.44 | (0.57) | 5.08 | 5.46 | 5.95 | 3.26 | 6.47 | 3.66 |
% margin | 2,608.6 7.0% | 3,174.9 7.2% | 5,887.9 7.7% | 7,341.0 8.4% | 7,819.0 8.0% | 7,609.0 7.9% | 7,903.0 7.4% | 8,619.0 7.0% | 9,915.0 7.8% | 10,224.0 7.3% | 11,567.0 7.5% | 12,190.0 6.9% | 11,809.0 6.4% | 6,743.0 3.5% | 16,403.0 6.4% | 17,118.0 6.4% | 17,526.0 6.0% | 12,347.0 3.8% | 18,197.0 5.1% | 13,703.0 3.7% |
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
FAQ
1) What is CVS Health Corporation's Gross margin?
As of today, Microsoft Corp's last 12-month Gross margin is 13.8%, based on the financial report for Dec 31, 2024 (Q4’2024). The average annual Gross margin for CVS Health Corporation have been 16.2% over the past three years, and 17.6% over the past five years.
2) Is CVS Health Corporation's Gross margin Good?
As of today, CVS Health Corporation's Gross margin is 13.8%, which is lower than industry median of 34.2%. It indicates that CVS Health Corporation's Gross margin is Bad.